SCHEMBL31013255

SCHEMBL31013255

COC(=O)C1(C)CCN(c2ncc(C(F)(F)F)cc2N)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 9/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPT P10636 4/20 0.43
KDM4E B2RXH2 2/20 0.43
HTT P42858 2/20 0.43
NR1I2 O75469 1/20 0.43
CACNA1C Q13936 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31013274 0.85 CXCR3 (0.49) SCN10ASMN1; SMN2LMNAMEN1KMT2A
SCHEMBL31013258 0.82 SMN1; SMN2 (0.44) SCN10ASMN1; SMN2LMNAMEN1KMT2A
SCHEMBL31013294 0.76 MAPT (0.55) SCN10ASMN1; SMN2LMNAMEN1KMT2A
SCHEMBL31410462 0.74 MEN1 (0.56) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL31410510 0.74 MEN1 (0.56) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL31013268 0.73 SMN1; SMN2 (0.50) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL1282773 0.73 OPRK1 (0.44) SCN10A
SCHEMBL3435696 0.73 OPRK1 (0.42) SCN10ASMN1; SMN2LMNAMAPTCYP2C19
SCHEMBL31013296 0.72 CXCR3 (0.51) SCN10ASMN1; SMN2LMNAMEN1KMT2A
SCHEMBL21906068 0.71 SCN10A (0.56) SCN10AMEN1KMT2ANR1I2CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646263-A1 SPRK1 INHIBITORS AND METHODS OF USE Allianthera (Suzhou) Biopharmaceutical Co., Ltd. (CN) 2025-11-12 EP disclosed
WO-2024155864-A1 SPRK1 INHIBITORS AND METHODS OF USE ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2024-07-25 WO disclosed